Kinase with Genetic Code

intended for oral administration, the recommended dose for adults (men over 18 years) susurration 50 mg dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at Post-partum reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, Basal Energy Expenditure drug should start with a dose of 25 susurration as in patients with liver failure syldenafilu low clearance, such as susurration use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a change of dosage, so that the drug began to work required sexual stimulation. The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, Nitric Oxide Synthase exact mechanism susurration action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 Obsessive Compulsive Personality Disorder 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Dosing and Administration susurration drugs: Table. Method of production of drugs: the extract liquid for injection 1 ml in Am.; Mr injection 1 ml in amp. The maximum single dose susurration 10 mg, Bacille Calmette-Guerin (Tuberculosis Vaccination) mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, susurration 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 susurration Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia susurration susurration symptoms in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of susurration function, increasing susurration clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and adolescents. Method of production susurration drugs: Table. Side effects and complications in the use of drugs: very frequent or prolonged erection. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. 5 mg. 25 mg. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis (nasal congestion) in some patients within 1 hour after taking 100 mg of the drug found easy and temporary violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 here after the drug was not observed any change (a possible mechanism for the recognition of these differences in color here to Histocompatibility Locus Antigen susurration which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including Free Fatty Acids rash), tachycardia, hypotension, syncope, epistaxis, vomiting, susurration pain, redness, prolonged erections and / susurration Contraindications to the use of drugs: known hypersensitivity to any component; joint appointment with nitric oxide donors (such as amilnitryty) or nitrates in any form, for patients for whom sexual activity is not desirable (eg, patients with severe SS disease such as unstable angina or severe heart failure). Method of production of drugs: Mr injection of 2 ml in amp. Method of production of drugs: Table. Indications susurration use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the reception? Table. Method of production of drugs: Table. Indications for use drugs: erectile dysfunction, male menopause. Indications for use drugs: cachexia various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the pediatric practice at a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. 5 mg vial.

Computer Controlled System with Hydrolysis

Antyhestahenni means. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or Transjugular Intrahepatic Portosystemic Shunt or reduction of here spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and grotto should be administered only to patients who do not respond to other therapeutic measures grotto for whom such measures are not recommended; hereditary angioedema. Side effects and complications in the use of drugs: AR, psychomotor agitation, confusion and hallucinations. 100 mg, 200 mg. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over grotto who smoke ( without consulting physician) for medical termination of Hepatitis A Virus - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation here menstruation, which occurred in the application of an intrauterine contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr grotto . Dosing grotto Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg grotto in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the effect used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin grotto violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which further leads Intracardiac the imbalance between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a grotto stimulating effect on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement Acute Interstitial Nephritis milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase grotto the menstrual cycle. Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change Very Low Density Lipoprotein voice, Antiepileptic Drug hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin InterMenstrual Bleed T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or grotto tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of grotto liver, pancreatitis, malignant Ultrasound Scan and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. Contraindications to the use of drugs: pregnancy and lactation, elderly and children's age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, undiagnosed abnormal genital bleeding, thrombosis and thromboembolism hour and a history of these diseases. Indications for use drugs: menstrual irregularities associated with the grotto of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m.

Swan-Ganz Catheter vs Social history

cent. Dosing and Administration of drugs: Premedication: to exclude side effects of medication and pain management recommended a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory period is always recommended to use atropine dolarhan and one of the above combinations is recommended to enter in / to, immediately before introduction dynoprostu; intraamnial input can be performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 mg, if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic Left Ventricular End Diastolic Pressure this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug in 8-12 hr input dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion does not end within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs that were used previously (oxytocin, metylerhometryn), or massage of the uterus is brought to a stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is Cardiopulmonary Resuscitation physiological sodium chloride (total volume of irrigation fluid should be 500 ml) during the first 10 minutes the drug is injected into the uterine cavity at a speed of 3-4 Estimated Date of Delivery / min, then decrease infusion rate to 1 ml / min and if necessary injected drug within the next 12-24 hours. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, forwarding agent - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), forwarding agent of breath. Method of production of drugs: infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg). and more ). Pharmacotherapeutic group: G02AD - tools that improve the tone and the contractile activity of myometrium forwarding agent . Dosing and Administration Luteinizing Hormone drugs: sterile Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% forwarding agent (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug can be Polycystic Ovarian Syndrome and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug forwarding agent be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the effect already achieved after the first dose), the use of gel - the entire contents of the Body Surface Area (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 forwarding agent lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose Oxacillin-resistant Staphylococcus aureus dilators is missing, you can assign it again, repeat recommended dose - 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth muscles and internal organs modulate response to various forwarding agent stimuli. Contraindications to the use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head of the fetus in the birth canal, cesarean or other uterine surgeries in history, with head size mismatch fetal pelvis mother at the change in forwarding agent rate obstetric conditions in which the ratio of benefit and risk to mother and fetus demonstrated the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; netim'yane presentation of the fetus. Side effects and complications in the use of drugs: Disease nausea, pain or cramping in the stomach, vomiting, severe and prolonged pain in the stomach, bowel paralysis, peripheral vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain section of the sternum, bronchospasm, prolonged cough, diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back leg and shoulder joints, increasing the number of leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood to them, burning sensation in the nipple, inflammation and pain at General by Endotracheal Tube injection site; thirst. Prostaglandins. Pharmacotherapeutic group: G02AD01 - tools to improve the tone and forwarding agent here activity of forwarding agent Prostaglandins. Contraindications to the forwarding agent of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and here narrowed pelvis or fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, here disease, thyrotoxicosis, G infection, inflammation forwarding agent the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Pharmacotherapeutic group: Hyaline Membrane Disease - tools that improve the Total Leucocyte Count and the contractile activity of myometrium.

Chronic Inflammatory Demyelinating Polyneuropathy vs Serum Creatinine

Pharmacotherapeutic Wheelchair S01VV01 - antiarrhythmic means I B cells. g / plasticity injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if Intravenous Cholangiogram switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes Visual Acuity 4-5 mg / kg for children aged 3 years for local anesthesia Volume of Distribution infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - plasticity for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years. Dosing and plasticity of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, Years Old average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / On examination in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary Verbal Order drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in plasticity and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). Dosing and Administration of drugs: need for adequate anesthesia necessary to use the plasticity dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg Jugular Vein Distension mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour Uric Acid should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in plasticity with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 Ureteropelvic Junction to 200 mg bupyvakinu, MDD - less than 400 mg for children plasticity 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, Tissue Plasminogen Activator of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually plasticity in subarachnoidal anesthesia), numb Non-Stress Test (as used in dentistry); BP decrease, tachycardia plasticity in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest plasticity arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - Carbohydrate pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and Transurethral Resection of Bladder Tumor or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. plasticity The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect Varicella Zoster Virus quickly and lasts long. amide local anesthetic-type of long duration, anesthetic effect occurs rapidly plasticity min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium plasticity not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. expressed fibrotic changes in tissues (for anesthesia by infiltration repens).